Cord Blood Banking & Stem Cell Research News


As the full potential of cord blood is as yet unknown, there is a great deal of research currently being undertaken to discover its capabilities.
Cord blood transplantation as a treatment for children with hematological, immunological, metabolic, and neoplastic diseases has been highly successful. The advantage of cord blood transplants is the relatively low rate of graft-versus-host disease (GVHD) compared with the rates of GVHD that occur as a result of bone marrow or peripheral blood transplants. Research related to the improved clinical use of cord blood is being conducted in four general areas: (1) enhancement of cord blood engraftment, (2) improvements in immune reconstitution, (3) reduction in the rates of treatment-related mortality, and (4) augmentation of immune recognition of infectious agents and tumors.


Further research is needed to better understand how cord blood may be used as a source of effector cells (i.e., performing a specific function in the immune system in response to a stimulus) outside the transplant setting. This includes the development of immune regulatory cells that might be useful in solid-organ transplant or for the treatment of autoimmune diseases. Cord blood could also be a source of pluripotent stem cells. Research suggests that these pluripotent stem cells, which are capable of differentiation into, for example, hepatocytes and neural progenitor cells, might be present in cord blood.

Research that may improve the effectiveness of cord blood transplantation for the treatment of a variety of conditions is ongoing, including: nonmyeloblative regimens; the use of ex vivo expansion to increase the numbers of HPCs and the development of new approaches to the acceleration of immune recovery; the use of multiple units in transplantation; the coinfusion of mesenchymal stem cells (MSC); and facilitation of the upregulation of homing receptors.


Can't find what you're looking for ? Try Google Search

Stem Cells

Stem Cell Research


Stem Cell Transplant Indications

 Thalassemias
• α-thalassemia intermedia (hemoglobin H disease)
• α-thalassemia major (hydrops fetalis)
• β-thalassemia major (Cooley’s anemia)
• β-thalassemia intermedia
• E-β° thalassemia
• E-β+ thalassemia

 Sickle Cell disorders
• Sickle cell anemia (hemoglobin SS)
• HbSC disease
• Sickle β° thalassemia
• Sickle β+ thalassemia

 Oncologic Disorders
• Acute lymphoblastic leukemia 
• Acute myeloid leukemia 
• Chronic myeloid leukemia
• Autoimmune lymphoproliferative syndrome
• Burkitt lymphoma 
• Cytopenia related to monosomy 7 
• Familial histocytosis 
• Juvenile myelomonocytic leukemia 
• Hemophagocytic lymphohistiocytosis 
• Hodgkin’s disease 
• Non-Hodgkin’s lymphoma 
• Langerhans cell histiocytosis
• Lymphatoid granulomatosis
• Myelodysplasia syndrome

 Hematologic Disorders                         
• Amegakaryocytic thrombocytopenia 
• Autoimmune neutropenia (severe)                 
• Congenital dyserythropoietic anemia      
• Cyclic neutropenia                                    
• Diamond Blackfan anemia                           
• Evan’s syndrome            
• Fanconi anemia                                                     
• Glanzmann’s disease                                          
• Hypoproliferative anemia                                        
• Juvenile dermatomyositis                                           
• Juvenile xanthogranulomas                
• Kostmanns syndrome 
• Pancytopenia 

• Red cell aplasia
• Refractory anemia
• Schwachman Syndrome
• Severe aplastic anemia
• Systemic mastocytosis
• Severe neonatal thrombocytopenia
• Congenital sideroblastic anemia
• Thrombocytopenia with absent radius(TAR syndrome)

 Immune Deficiencies
• Ataxia telangectasia 
• Cartilage-hair hypoplasia
• Chronic granulomatous disease
• Hypogammaglobulinemia
• IKK gamma deficiency
• Immune dysregulation polyendocrinopathy
• Mucolipidosis, Type II
• Myelokathesis
• X-linked immunodeficiency
• Severe combined immunodeficiency
• Adenosine desaminase deficiency
• Wiscott-Aldrich syndrome
• X-linked agammaglobulinemia
• X-linked lymphoproliferative syndrom

 Metabolic Disorders
• Adrenoleukodystrophy
• Gaucher’s disease (infantile)
• Metachromatic leukodystrophy
• Globoid cell leukodystrophy(Krabbe d.) 
• Gunther disease
• Hermansky-Pudlak syndrome
• Hurler syndrome
• Hurler-Scheie syndrome
• Hunter Syndrome
• Sanfilippo syndrome
• Maroteau-Lamy Syndrome
• Mucolipidosis Types II, III
• Alpha mannosidosis
• Neimann Pick Syndrome, types AandB
• Sandoff Syndrome
• Tay Sachs Disease

 

 


Latest News In Stem Cell Research & Therapy


Awareness message

millionsoulsaware.org